会員登録
ログイン
【4588】オンコリスバイオファーマ
製薬。がん治療薬。
売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
| 決算期 | 日付 | 予・実 | 売上高 (百万円) |
対前回 | 修正率 | 修正率 | 営業利益 (百万円) |
対前回 | 修正率 | 修正率 | 経常利益 (百万円) |
対前回 | 修正率 | 修正率 | 当期利益 (百万円) |
対前回 | 修正率 | 修正率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023.12 | 2024/02/09 | 実 | 63 | → | 0.0% | 0.0% | -1,929 | ↓ | -6.8% | -6.8% | -1,913 | ↓ | -7.8% | -7.8% | -1,938 | ↓ | -9.1% | -9.1% |
| 2023.12 | 2023/12/15 | 当初予 | 63 | - | - | - | -1,806 | - | - | - | -1,775 | - | - | - | -1,777 | - | - | - |
| 2022.12 | 2023/02/10 | 実 | 976 | ↓ | -2.4% | -2.4% | -1,204 | ↑ | +24.8% | +24.8% | -1,163 | ↑ | +27.3% | +27.3% | -1,148 | ↑ | +28.2% | +28.2% |
| 2022.12 | 2022/11/04 | Q3予 | 1,000 | → | 0.0% | 0.0% | -1,600 | → | 0.0% | 0.0% | -1,600 | → | 0.0% | 0.0% | -1,600 | → | 0.0% | 0.0% |
| 2022.12 | 2022/08/05 | Q2予 | 1,000 | → | 0.0% | 0.0% | -1,600 | → | 0.0% | 0.0% | -1,600 | → | 0.0% | 0.0% | -1,600 | → | 0.0% | 0.0% |
| 2022.12 | 2022/05/13 | Q1予 | 1,000 | → | 0.0% | 0.0% | -1,600 | → | 0.0% | 0.0% | -1,600 | → | 0.0% | 0.0% | -1,600 | → | 0.0% | 0.0% |
| 2022.12 | 2022/02/10 | 当初予 | 1,000 | - | - | - | -1,600 | - | - | - | -1,600 | - | - | - | -1,600 | - | - | - |
| 2021.12 | 2022/02/10 | 実 | 642 | → | 0.0% | +22.3% | -1,454 | ↓ | -2.3% | +20.3% | -1,500 | ↓ | -2.2% | +17.8% | -1,615 | ↓ | -2.1% | +11.5% |
| 2021.12 | 2022/01/24 | 修正予 | 642 | ↑ | +22.3% | +22.3% | -1,421 | ↑ | +22.1% | +22.1% | -1,468 | ↑ | +19.6% | +19.6% | -1,582 | ↑ | +13.3% | +13.3% |
| 2021.12 | 2021/11/05 | Q3予 | 525 | → | 0.0% | 0.0% | -1,825 | → | 0.0% | 0.0% | -1,825 | → | 0.0% | 0.0% | -1,825 | → | 0.0% | 0.0% |
| 2021.12 | 2021/08/06 | Q2予 | 525 | → | 0.0% | 0.0% | -1,825 | → | 0.0% | 0.0% | -1,825 | → | 0.0% | 0.0% | -1,825 | → | 0.0% | 0.0% |
| 2021.12 | 2021/05/07 | Q1予 | 525 | → | 0.0% | 0.0% | -1,825 | → | 0.0% | 0.0% | -1,825 | → | 0.0% | 0.0% | -1,825 | → | 0.0% | 0.0% |
| 2021.12 | 2021/02/12 | 当初予 | 525 | - | - | - | -1,825 | - | - | - | -1,825 | - | - | - | -1,825 | - | - | - |
| 2020.12 | 2021/02/12 | 実 | 314 | - | - | - | -1,674 | - | - | - | -1,723 | - | - | - | -2,095 | - | - | - |
| 2019.12 | 2020/02/07 | 実 | 1,303 | - | - | - | -511 | - | - | - | -539 | - | - | - | -912 | - | - | - |
| 2018.12 | 2019/02/08 | 実 | 168 | ↑ | +5.0% | -27.0% | -1,247 | ↑ | +0.2% | +10.9% | -1,230 | ↑ | +1.6% | +12.1% | -1,233 | ↑ | +1.4% | +11.9% |
| 2018.12 | 2019/01/18 | 修正予 | 160 | ↓ | -30.4% | -30.4% | -1,250 | ↑ | +10.7% | +10.7% | -1,250 | ↑ | +10.7% | +10.7% | -1,250 | ↑ | +10.7% | +10.7% |
| 2018.12 | 2018/11/02 | Q3予 | 230 | → | 0.0% | 0.0% | -1,400 | → | 0.0% | 0.0% | -1,400 | → | 0.0% | 0.0% | -1,400 | → | 0.0% | 0.0% |
| 2018.12 | 2018/08/03 | Q2予 | 230 | → | 0.0% | 0.0% | -1,400 | → | 0.0% | 0.0% | -1,400 | → | 0.0% | 0.0% | -1,400 | → | 0.0% | 0.0% |
| 2018.12 | 2018/02/09 | 当初予 | 230 | - | - | - | -1,400 | - | - | - | -1,400 | - | - | - | -1,400 | - | - | - |
| 2017.12 | 2018/02/09 | 実 | 229 | ↑ | +14.5% | +14.5% | -1,078 | ↑ | +23.0% | +23.0% | -1,087 | ↑ | +22.4% | +22.4% | -1,090 | ↑ | +22.1% | +22.1% |
| 2017.12 | 2017/11/02 | Q3予 | 200 | → | 0.0% | 0.0% | -1,400 | → | 0.0% | 0.0% | -1,400 | → | 0.0% | 0.0% | -1,400 | → | 0.0% | 0.0% |
| 2017.12 | 2017/08/04 | Q2予 | 200 | → | 0.0% | 0.0% | -1,400 | → | 0.0% | 0.0% | -1,400 | → | 0.0% | 0.0% | -1,400 | → | 0.0% | 0.0% |
| 2017.12 | 2017/05/02 | Q1予 | 200 | → | 0.0% | 0.0% | -1,400 | → | 0.0% | 0.0% | -1,400 | → | 0.0% | 0.0% | -1,400 | → | 0.0% | 0.0% |
| 2017.12 | 2017/02/08 | 当初予 | 200 | - | - | - | -1,400 | - | - | - | -1,400 | - | - | - | -1,400 | - | - | - |
| 2016.12 | 2017/02/08 | 実 | 178 | ↓ | -5.3% | -5.3% | -861 | ↑ | +32.4% | +32.4% | -864 | ↑ | +32.1% | +32.1% | -931 | ↑ | +27.0% | +27.0% |
| 2016.12 | 2016/08/04 | Q2予 | 188 | → | 0.0% | 0.0% | -1,273 | → | 0.0% | 0.0% | -1,273 | → | 0.0% | 0.0% | -1,276 | → | 0.0% | 0.0% |
| 2016.12 | 2016/04/28 | Q1予 | 188 | → | 0.0% | 0.0% | -1,273 | → | 0.0% | 0.0% | -1,273 | → | 0.0% | 0.0% | -1,276 | → | 0.0% | 0.0% |
| 2016.12 | 2016/02/10 | 当初予 | 188 | - | - | - | -1,273 | - | - | - | -1,273 | - | - | - | -1,276 | - | - | - |
| 2015.12 | 2016/02/10 | 実 | 121 | ↑ | +2.5% | +15.2% | -951 | ↑ | +10.6% | +40.6% | -854 | ↑ | +19.7% | +43.4% | -857 | ↑ | +11.5% | +43.3% |
| 2015.12 | 2015/11/24 | 修正予 | 118 | ↑ | +12.4% | +12.4% | -1,064 | ↑ | +33.6% | +33.6% | -1,064 | ↑ | +29.5% | +29.5% | -968 | ↑ | +36.0% | +36.0% |
| 2015.12 | 2015/11/12 | Q3予 | 105 | → | 0.0% | 0.0% | -1,602 | → | 0.0% | 0.0% | -1,509 | → | 0.0% | 0.0% | -1,512 | → | 0.0% | 0.0% |
| 2015.12 | 2015/08/12 | Q2予 | 105 | → | 0.0% | 0.0% | -1,602 | → | 0.0% | 0.0% | -1,509 | → | 0.0% | 0.0% | -1,512 | → | 0.0% | 0.0% |
| 2015.12 | 2015/05/13 | Q1予 | 105 | → | 0.0% | 0.0% | -1,602 | → | 0.0% | 0.0% | -1,509 | → | 0.0% | 0.0% | -1,512 | → | 0.0% | 0.0% |
| 2015.12 | 2015/02/12 | 当初予 | 105 | - | - | - | -1,602 | - | - | - | -1,509 | - | - | - | -1,512 | - | - | - |
| 2014.12 | 2015/02/12 | 実 | 28 | → | 0.0% | -97.6% | -827 | ↑ | +0.4% | -710.8% | -726 | ↑ | +12.5% | -3125.0% | -738 | ↓ | -0.3% | -3614.3% |
| 2014.12 | 2015/01/23 | 修正予 | 28 | ↓ | -94.9% | -97.6% | -830 | ↓ | -13.1% | -713.7% | -830 | ↓ | -34.3% | -3558.3% | -736 | ↓ | -18.7% | -3604.8% |
| 2014.12 | 2014/11/12 | Q3予 | 544 | → | 0.0% | -53.3% | -734 | → | 0.0% | -619.6% | -618 | → | 0.0% | -2675.0% | -620 | → | 0.0% | -3052.4% |
| 2014.12 | 2014/08/12 | Q2予 | 544 | → | 0.0% | -53.3% | -734 | → | 0.0% | -619.6% | -618 | → | 0.0% | -2675.0% | -620 | → | 0.0% | -3052.4% |
| 2014.12 | 2014/05/13 | Q1予 | 544 | → | 0.0% | -53.3% | -734 | → | 0.0% | -619.6% | -618 | → | 0.0% | -2675.0% | -620 | → | 0.0% | -3052.4% |
| 2014.12 | 2014/04/14 | 修正予 | 544 | ↓ | -53.3% | -53.3% | -734 | ↓ | -619.6% | -619.6% | -618 | ↓ | -2675.0% | -2675.0% | -620 | ↓ | -3052.4% | -3052.4% |
| 2014.12 | 2014/02/14 | 当初予 | 1,164 | - | - | - | -102 | - | - | - | 24 | - | - | - | 21 | - | - | - |
| 2013.12 | 2014/02/14 | 実 | 1 | - | - | - | -665 | - | - | - | -625 | - | - | - | -635 | - | - | - |
